Press release
August 5, 2026
Cytek Biosciences Reports Second Quarter 2026 Financial Results
Cytek Biosciences, Inc. (CTKB)
FREMONT, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2026. Recent Highlights Total revenue for the second quarter